Prolinx Shuts its Doors; Life Science Research Grants in Europe, US Are Cut | GenomeWeb

These are dark days in some parts of the proteomics world, with industrial players and academics running out of cash. Prolinx of Bothell, Wash., which had developed molecular coupling chemistries with applications in protein microarrays and was working on an instrument for measuring biomolecular interactions by surface plasmon resonance, has closed its doors, according to a scientific advisor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.